Published in Obesity and Diabetes Week, November 22nd, 2010
Androgen deprivation therapy is a widely-prescribed treatment in men with prostate cancer, although its usage for low-risk disease remains controversial, given the adverse side effects, including osteoporosis, cardiovascular disease, diabetes and obesity; the last two are risk factors for colorectal cancer.
To determine whether prostate cancer patients taking androgen deprivation therapy are at an increased risk of colon cancer, Silke...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week